Teramed Targets Contraindicated Patients For AAA Stent Graft Market Entry
This article was originally published in The Gray Sheet
Executive Summary
Teramed's kick-off of clinical studies for the Ariba and Tributary abdominal aortic aneurysm stent graft systems indicates both the rapid pace of differentiating innovation in the AAA market and industry's continued interest in minimally invasive surgical solutions to vascular disease.